Abiraterone
규격
154229-19-3CAS 번호
810-941-6EC 번호
(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-olIUPAC 명칭
C24H31NO화학식
349.5 g/mol분자량
Abiraterone; 154229-19-3; CB 7598; CB-7598; 17-(3-Pyridyl)androsta-5,16-dien-3beta-ol; CB7598; Abiraterona; 17-(pyridin-3-yl)androsta-5,16-dien-3beta-ol; G819A456D0; NSC-741232; (3beta)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol; (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol; Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3beta)-; CHEBI:68642; DTXSID80879993; abirateronum; (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta(a)phenanthren-3-ol; RefChem:57133; L02BX03; DTXCID501021626; (3beta)-17-(3-pyridinyl)-androsta-5,16-dien-3-ol; Abiraterone (CB-7598); (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol; MFCD00924100; CHEMBL254328; 17-(3-Pyridyl)androsta-5,16-dien-3.beta.-ol; (3beta)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol; Abiraterone [INN:BAN]; (3-beta)-17-(3-Pyridinyl)-androsta-5,16-dien-3-ol; Abirateron;; UNII-G819A456D0; Abiraterone; CB 7598; (3beta)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol; 17-(3-Pyridinyl)-androsta-5,16-dien-3beta-ol; 154229-19-3 (Abiraterone); Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3b)-; Abiraterone (Standard); ABIRATERONE [MI]; ABIRATERONE [INN]; ABIRATERONE [VANDF]; CB 7630 [as acetate]; SCHEMBL61108; ABIRATERONE [WHO-DD]; MLS006010235; US9487554, Abiraterone; GTPL6745; orb1300971; orb3141293; Abiraterone - Bio-X trade mark; SCHEMBL29359971; BDBM25458; EX-A106; GZOSMCIZMLWJML-VJLLXTKPSA-N; ABIRATERONE [USP IMPURITY]; GLXC-07971; EBC-13814; HY-70013R; NSC749226; AKOS005146525; CS-0156; DB05812; ES-0045; FA16899; NSC 741232; NSC-749226; US9611270, Example 5, abiraterone; NCGC00263148-04; (3aS,3bR,7S,9aR,9bS,11aS)-9a,11a-dimethyl-1-(pyridin-3-yl)-3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol; (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(3-pyridyl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol.; AC-25764; BA164060; HY-70013; SMR002530050; A0534; A2868; T6216; 17-(3-Pyridyl)androsta-5.16-dien-3beta-ol; EN300-311691; AB01274738-01; AB01274738_02; F222701; Q321431; SR-01000941584; (3b)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol; SR-01000941584-1; (3|_)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol; BRD-K50071428-001-01-7; BRD-K50071428-001-03-3; Z2301684603; 17-(PYRIDIN-3-YL)ANDROSTA-5,16-DIEN-3.BETA.-OL; Zytiga; (3b)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol; Abiraterone/(3|A)-17-(Pyridin-3-yl)-androsta-5,16-dien-3-ol; ANDROSTA-5,16-DIEN-3-OL, 17-(3-PYRIDINYL)-(3.BETA.)-; (1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-(pyridin-3-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,13-dien-5-ol동의어